Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385021
Status:
TERMINATED
Last Update Posted:
2007-11-02
First Post:
2006-10-04
Brief Title:
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
Sponsor:
Southwestern Regional Medical Center
Organization:
Southwestern Regional Medical Center
Study Overview
Official Title:
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
Status:
TERMINATED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine efficacy in the delivery of chronomodulated chemotherapy
Detailed Description:
The purpose of this study is to determine if treatment with 5-Fluorouracil leucovorin oxaliplatin and Avastin will cause colorectal tumor cells to shrink or disappear The study will also determine the safety of these drugs when given together and the quality of life of the patients who are enrolled in the study
It is thought that these drugs will be better tolerated if they are chronomodulated ie if they are given at certain times of day rather than as a continuous infusion
It is thought that these drugs will be better tolerated if they are chronomodulated ie if they are given at certain times of day rather than as a continuous infusion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None